Back | Next |
home / stock / nlnk / nlnk message board
Subject | By | Source | When |
---|---|---|---|
This is January Effect Play! The reasoning was | VivaLasVegas | investorshub | 12/21/2019 12:59:47 AM |
* * $NLNK Video Chart 12-20-2019 * * | ClayTrader | investorshub | 12/20/2019 10:23:48 PM |
News: $NLNK NewLink Genetics Announces FDA Approval of | whytestocks | investorshub | 12/20/2019 4:15:28 PM |
Claytrader predicts horizontal lines. | willlbone | investorshub | 10/15/2019 2:56:13 PM |
* * $NLNK Video Chart 10-01-2019 * * | ClayTrader | investorshub | 10/01/2019 9:51:59 PM |
* * $NLNK Video Chart 09-18-2019 * * | ClayTrader | investorshub | 09/18/2019 9:08:10 PM |
News: $NLNK NewLink Genetics Presents Updated NLG802 Results | whytestocks | investorshub | 05/23/2019 12:50:39 PM |
* * $NLNK Video Chart 03-19-2019 * * | ClayTrader | investorshub | 03/19/2019 9:38:44 PM |
What a shock...after Clay, no new posts. | lemmy | investorshub | 12/29/2018 1:04:54 AM |
* * $NLNK Video Chart 11-15-18 * * | ClayTrader | investorshub | 11/15/2018 10:43:35 PM |
Agreed. They said they would need $10 mil | GunShow_Trader | investorshub | 08/01/2018 4:41:59 AM |
Im hoping theyre doing it because they see | terry hallinan | investorshub | 08/01/2018 4:27:46 AM |
Im hoping theyre doing it because they see | GunShow_Trader | investorshub | 08/01/2018 1:29:08 AM |
$NLNK retrenchment: | terry hallinan | investorshub | 07/31/2018 9:18:49 PM |
NewLink Genetics Announces Positive Updated Phase 1 Data | terry hallinan | investorshub | 07/02/2018 2:33:38 PM |
http://www.stockscores.com/charts/charts/?ticker=$NLNK | mick | investorshub | 04/07/2018 5:06:34 PM |
* * $NLNK Video Chart 04-06-18 * * | ClayTrader | investorshub | 04/06/2018 9:18:53 PM |
NewLink Genetics Announces Review of Clinical Programs Source: GlobeNewswire | T695 | investorshub | 04/06/2018 7:14:07 PM |
scared people shouldn't invest all this selling has | gregque | investorshub | 04/06/2018 6:36:12 PM |
Bounce coming it look like | T695 | investorshub | 04/06/2018 5:22:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock Kahn Swick & Foti, LLC Announces Summary Notice of Proposed Settlement Involving Purchasers of NewLink Common Stock PR Newswire NEW ORLEANS ...
AUSTIN, Texas, March 30, 2020 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, has announced the appointment of Joseph S. McCracken, DVM, MS to the company's Board of Directors, effective March 23...
- Combined company, Lumos Pharma, Inc., to trade on Nasdaq under the stock symbol “LUMO” - Phase 2b trial expected to be initiated mid-2020 evaluating oral therapeutic candidate LUM-201 (ibutamoren) in Pediatric Growth Hormone Deficiency (PGHD) - Projected combined cash ...